Nuvalent (NUVL) Invested Capital (2020 - 2026)
Nuvalent (NUVL) reported Invested Capital of $1.2 billion for Q1 2026, up 16.15% on a YoY basis from $1.0 billion in Q1 2025, and down 5.93% quarter-over-quarter from $1.2 billion in Q4 2025.
Nuvalent (NUVL) Invested Capital (2020 - 2026) Analysis & Trends
Nuvalent has reported Invested Capital for 7 years, with the latest figure at $1.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital rose 16.15% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 16.15% YoY), and the FY2025 full-year result was $1.2 billion, up 16.69% from the prior year.
- Invested Capital for Q1 2026 stood at $1.2 billion, down from $1.2 billion in the prior quarter.
- The five-year high for Invested Capital was $1.2 billion in Q4 2025, with the low at $236.6 million in Q3 2022.
- Historically, Invested Capital has averaged $700.3 million across 5 years, with a median of $675.0 million in 2024.
- Annual changes were most pronounced in 2022 — Invested Capital jumped 796.22% — and 2025, when it decreased 24.59%.
- Nuvalent's Invested Capital stood at $463.0 million in 2022, then surged by 51.32% to $700.6 million in 2023, then jumped by 52.71% to $1.1 billion in 2024, then grew by 16.69% to $1.2 billion in 2025, then dropped by 5.93% to $1.2 billion in 2026.
- The last three Invested Capital figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $845.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 502.95 Mn |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 845.40 Mn |
| Jun 30, 2025 | 939.74 Mn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 637.04 Mn |
| Mar 31, 2024 | 675.04 Mn |
| Dec 31, 2023 | 700.56 Mn |
| Sep 30, 2023 | 395.98 Mn |
| Jun 30, 2023 | 421.15 Mn |
| Mar 31, 2023 | 443.97 Mn |
| Dec 31, 2022 | 462.98 Mn |
| Sep 30, 2022 | 236.58 Mn |
| Jun 30, 2022 | 252.99 Mn |
| Mar 31, 2022 | 268.92 Mn |
| Dec 31, 2021 | 285.04 Mn |
| Sep 30, 2021 | 301.13 Mn |
| Jun 30, 2021 | -47.74 Mn |